BRAIN CANCER ENQUIRIES
Melanoma Institute Australia (MIA) has received many enquiries regarding the treatment given to one of our Co-Medical Directors, Prof Richard Scolyer AO, who has been diagnosed with brain cancer. We understand the difficult situation faced by many brain cancer patients and their families and the many people who have been following Prof Scolyer’s journey. However, we are unfortunately not in a position to respond to individual enquiries seeking advice about access to brain cancer treatment or enrolment onto brain cancer clinical trials.
MIA is a melanoma and skin cancer research and treatment centre, and we do not provide clinical consultation or conduct clinical trials in relation to brain cancer. We strongly advise all brain cancer patients to continue to consult with their own medical teams.
Data generated from the experimental treatment given to Prof Scolyer has been submitted for publication in a leading medical journal and is currently undergoing external peer review. It is hoped that this data will prompt leading institutions within the brain cancer sector to open new clinical trials in the near future.
Our melanoma patients remain at the centre of everything we do here at MIA as we continue to strive towards achieving our mission of zero deaths from melanoma.
Matthew Browne
Chief Executive Officer
24 June 2024
LATEST NEWS
Be part of a research study about genetic information, support and testing
Patients, and families of patients, impacted by advanced melanoma are invited to participate in an online interview to explore their views, experiences, and needs related to genetic information, support and testing.
Together, Amplifying Impact at #AMC2024
Hosted by MIA in Sydney, AMC2024 brought together 776 multidisciplinary delegates to engage in insightful discussions, presentations and workshops, all dedicated to reaching our common goal of zero deaths from melanoma. See our AMC2024 photo album.
Creative and courageous Community Fundraisers
The creative ways our dedicated community fundraise for MIA never ceases to amaze us! We are so appreciative of their efforts, which help fund our life-saving research.
MIA urges sun safe practices at work this National Safe Work Month
MIA urges workplaces to enforce sun safe practices this National Safe Work Month, with Speakers' Hub presenter Andrew Camfield sharing his story with 400 Blacktown City Council tradies.
His Majesty King Charles III meets with MIA
We were delighted to have the honour of meeting with His Majesty King Charles III this week, a once-in-a-lifetime opportunity to shine an international spotlight on melanoma.
MIA’s MISSION
ZERO DEATHS FROM MELANOMA
MIA will achieve its mission through 3 pillars of action: Research, Clinical Care & Education.
MIA conducts its research under 4 themes: Prevention, Risk & Clinical Detection – Early Melanoma – Advanced Melanoma – Supportive Care & Survivorship.
1300
It is estimated 1300 Australians will die from melanoma this year
30 mins
1 Australian is diagnosed with melanoma every 30 minutes
90%
If caught early 90% of melanomas can be cured by surgery
Age 20-39
Melanoma is the most common cancer affecting Australians aged 20 to 39
